Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy: A potential of hormone-guided treatment☆
To access this article, please choose from the options below
☆ Reprint requests: Katsuya Hata, MD, PhD, FACC, First Department of Internal Medicine, Kobe University School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
PII: S0002-8703(01)86782-X
doi:10.1067/mhj.2001.115435
© 2001 Mosby, Inc. All rights reserved.
